cyfluthrin has been researched along with Chlamydia Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukofzer, S; Hammerschlag, MR; Ramirez, J; Reznik, T; Roblin, PM; Summersgill, J | 1 |
| Fukano, H; Matsushima, T; Miyashita, N; Niki, Y; Yoshida, K | 1 |
| Hammerschlag, MR; Reznik, T; Roblin, PM; Strigl, S | 1 |
1 trial(s) available for cyfluthrin and Chlamydia Infections
| Article | Year |
|---|---|
Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Topics: Adult; Aged; Chlamydia Infections; Chlamydophila pneumoniae; Double-Blind Method; Erythromycin; Female; Humans; Ketolides; Male; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
2 other study(ies) available for cyfluthrin and Chlamydia Infections
| Article | Year |
|---|---|
In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Erythromycin; Humans; Japan; Ketolides; Macrolides; Microbial Sensitivity Tests | 2003 |
In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
Topics: Chlamydia Infections; Chlamydophila pneumoniae; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests | 2000 |